Bakir Ekinci, P. Et Al. 2022. Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3 , 1387-1391.

Bakir Ekinci, P., KARA, E., ER, A. G., İNKAYA, A. Ç., Demirkan, K., & UZUN, Ö., (2022). Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, 1387-1391.

Bakir Ekinci, Pinar Et Al. "Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels," BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, 1387-1391, 2022

Bakir Ekinci, Pinar B. Et Al. "Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, pp.1387-1391, 2022

Bakir Ekinci, P. Et Al. (2022) . "Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, pp.1387-1391.

@article{article, author={Pinar Bakir Ekinci Et Al. }, title={Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels}, journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY}, year=2022, pages={1387-1391} }